| Consumer Finance Industry | Financials Sector | Ms. Jun'e Yan CEO | XSHE Exchange | CNE100005WP6 ISIN |
| CN Country | 2,608 Employees | 12 Jun 2026 Last Dividend | 12 Jun 2026 Last Split | - IPO Date |
Mehow Innovative Ltd. operates at the forefront of the medical device industry, engaged in the intricate processes of designing, developing, manufacturing, and selling precision components and products aimed at enhancing medical care. With its roots established in 2010, the company has spread its presence beyond its headquarters in Shenzhen, China, reaching out to markets on an international scale. It specializes in a range of innovative medical devices and equipment that cater to critical health care needs, reflecting the company’s commitment to leveraging technology for better health outcomes.
These devices supply critical support for patients requiring assistance with respiration, offering various modes of ventilation tailored to individual needs. Mehow Innovative Ltd. contributes to respiratory care by providing advanced ventilator equipment that enhances patient comfort and therapy effectiveness.
Integral to the domain of audiological advancements, the company manufactures components used in cochlear implants. These products play a pivotal role in restoring the sense of hearing to individuals with profound hearing loss, showcasing Mehow Innovative’s commitment to improving quality of life through innovation.
By delivering high-precision molds and state-of-the-art automation equipment, Mehow supports the mass production of medical devices with unparalleled accuracy. This service not only ensures the consistency and reliability of medical components but also streamlines the manufacturing process for various medical applications.
These instruments are essential for diagnosing and monitoring respiratory conditions, offering accurate measurements of lung capacity and air flow. Mehow Innovative Ltd.’s contributions to respiratory diagnostics aid in the early detection and management of pulmonary diseases.
Specializing in the analysis of exhaled gases, the company offers equipment and consumables for detecting metabolic and respiratory markers. This technology serves as a non-invasive method for monitoring health and diagnosing conditions, reinforcing Mehow’s role in advancing diagnostic capabilities.